c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
IDEAYA Biosciences (IDYA) Advances IDE101 as Dual CDK Inhibitor Targeting CDKN2A Deficiency
GuruFocus | Nov 15, 2026 4:25 PM EST
Related Stocks: IDYA ,
Read original article